1-7 of 7
Yvonne Dei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double-Blind, Placebo-Controlled Randomized Controlled Trial of Hydroxyurea for HbSC: Results of the Prospective Identification of Variables As Outcomes for Treatment (PIVOT) Trial

Yvonne Dei-Adomakoh, Catherine I. Segbefia, Teresa S. Latham, Adam C. Lane, Klenam Dzefi-Tettey, Kwesi N. Amissah-Arthur, Oksana Corquaye, Lyudmyla Korang, Enoch Mensah, Priscilla Ekpale, William K Ghunney, Lily Tagoe, Alpha Oteng, Emmanuella Amoako, Ernestina Schandorf, Enam Bankas, Nana Awuku, Doreen Seedah, Susan E. Stuber, Luke R. Smart, Russell E. Ware
Journal: Blood
Blood (2024) 144 (Supplement 1): 3.
https://doi.org/10.1182/blood-2024-204408
Published: 2024
Journal Articles

An e-Health Pain Assessment Tool Incorporating Animations and Images Is Feasible and Useful for Patients in a Ghanaian Sickle Cell Disease Cohort

Modesty Obasohan, Catherine I. Segbefia, Charles R. Jonassaint, Eugenia Vicky Asare, Yvonne Dei Adomakoh, Cheryl Hillery, Olubusola Oluwole
Journal: Blood
Blood (2024) 144 (Supplement 1): 606.
https://doi.org/10.1182/blood-2024-198985
Published: 2024
Journal Articles

Impact of Iron Supplementation in Anemic Voluntary First-Time Blood Donors-Results of a Pilot Trial in Ghana

Yvonne Dei Adomakoh, Edeghonghon Olayemi, Lucy Asamoah-Akuoko, Bernard Appiah, Susan Telke, Catherine I. Segbefia, Tara Tancred, Seth Adu-Afarwuah, Amma A. Benneh-Akwasi Kuma, Alfred Edwin Yawson, Solomon Fiifi Ofori-Acquah, Philip Baba Adongo, Reena Ametorwo, Imelda Bates, Cavan Reilly, The BLOODSAFE Investigators
Journal: Blood
Blood (2023) 142 (Supplement 1): 1290.
https://doi.org/10.1182/blood-2023-174351
Published: 2023
Journal Articles

Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Miguel R Abboud, Rodolfo D Cançado, Mariane De Montalembert, Wally R Smith, Hala Rimawi, Ersi Voskaridou, Birol Guvenc, Deborah Keefe, Kai Grosch, Michele L Nassin, Jimmy Watson, Justin Yssel, Evgeniya Reshetnyak, Yvonne Dei Adomakoh
Journal: Blood
Blood (2023) 142 (Supplement 1): 272.
https://doi.org/10.1182/blood-2023-185429
Published: 2023
Journal Articles

Prospective Identification of Variables As Outcomes for Treatment (PIVOT): A Phase II Clinical Trial of Hydroxyurea for Children and Adults with HbSC Disease

Catherine I. Segbefia, Luke R. Smart, Susan E. Stuber, Priscilla Ekpale, Kwesi N. Amissah-Arthur, Klenam Dzefi-Tettey, Enoch Mensah, Adam C. Lane, Diana Dwuma-Badu, Teresa S. Latham, Yvonne Dei-Adomakoh, Russell E. Ware
Journal: Blood
Blood (2023) 142 (Supplement 1): 3877.
https://doi.org/10.1182/blood-2023-190351
Published: 2023
Journal Articles

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

Abdullah Kutlar, Vikas Joshi, Andreas Brueckner, Julie Kanter, Darla K. Liles, Jeremie Lincy, Rahul Manjare, Yvonne Dei Adomakoh, Matthew M. Heeney, Mariane de Montalembert, Deborah Keefe, Kwaku Marfo, Kenneth I. Ataga
Journal: Blood
Blood (2023) 142 (Supplement 1): 1139.
https://doi.org/10.1182/blood-2023-188639
Published: 2023
Journal Articles

Tropical Splenic Lymphoma: Splenic Marginal Zone Lymphoma or Distinct Entity?.

Elizabeth A. Stephens, MBBS, Imelda Bates, MD, George Bedu-Addo, Ivy Ekem, Yvonne Dei, Ohene K. Opare-Sem, Sheila J.M. O’Connor, PhD, Paul A.S. Evans, PhD, Rebecca A. Rollett, BSc, Roger G. Owen, MD
Journal: Blood
Blood (2006) 108 (11): 4654.
https://doi.org/10.1182/blood.V108.11.4654.4654
Published: 2006